M. Sextro
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 8
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Volker Diehl (8 shared papers)Dirk Hasenclever (5 shared papers)Matthias W. Haenel (1 shared paper)Susanne Decker (1 shared paper)Markus Sieber (1 shared paper)Peter E. Müller (1 shared paper)F. Boissevain (1 shared paper)Andreas Lohri (1 shared paper)
In The Last Decade
M. Sextro
10 papers receiving 1.5k citations
M. Sextro's Hit Papers
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 1.3k
- Neurology 445
- Genetics 315
- Oncology 745
- Hematology 139
Countries citing papers authored by M. Sextro
This map shows the geographic impact of M. Sextro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sextro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sextro more than expected).
Fields of papers citing papers by M. Sextro
This network shows the impact of papers produced by M. Sextro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sextro. The network helps show where M. Sextro may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Sextro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Hit paper breakdown → | 2002 | 762 |
| 2 | 1999 | 248 | |
| 3 | 2000 | 190 | |
| 4 | 1998 | 144 | |
| 5 | 2000 | 84 | |
| 6 | Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. | 1997 | 55 |
| 7 | Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. | 1996 | 39 |
| 8 | 1996 | 19 | |
| 9 | 2001 | 10 | |
| 10 | 2000 | 7 |
About M. Sextro
M. Sextro is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Epidemiology and Neurology, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (3 papers), Viral-associated cancers and disorders (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Renal and Vascular Pathologies (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.3k citations), Neurology (445 citations), Genetics (315 citations), Oncology (745 citations) and Hematology (139 citations). M. Sextro has collaborated with scholars based in Germany, Finland and Italy. Frequent co-authors include Volker Diehl, Dirk Hasenclever, Matthias W. Haenel, Susanne Decker, Markus Sieber, Peter E. Müller, F. Boissevain, Andreas Lohri, Beate Pfistner and Angelo Michele Carella. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Annals of Hematology, Blood and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.